$2.060
-0.049 (-2.37%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
PCSA 相似圖表分析預測
Alphio's PCSA stock price prediction model matches the current Processa Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.05 (-0.64%). The 1-week path is $2.10 (+2.11%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Processa Pharmaceuticals Inc 股票嗎？
Currently, Processa Pharmaceuticals Inc (PCSA) is not a good buy. The stock has dropped 56.19% over the past year and has a low RSI of 31.285, indicating it is oversold. Additionally, the forward P/E ratio is 0, suggesting no earnings growth is expected in the near future. The recent acquisition of Vidya, while potentially beneficial long-term, led to a sharp 38% drop in stock price, highlighting market skepticism. The main risk is the company's negative net income, which stood at -3,265,494 USD in Q2 2026, indicating ongoing financial struggles.
PCSA 股價於 Friday 收在 $2.06，此前下跌 -2.37%
Processa Pharmaceuticals Inc (PCSA) last closed at $2.06, losing -2.37%. These facts feed the 1-day and 1-week PCSA price prediction above.
預測驅動因素
Processa Pharmaceuticals Inc（PCSA）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 PCSA 最接近的股票，依相似度排序。
PCSA 季節性分析
Historically the probability of a positive August return for PCSA is 0.00%. January offers the highest probability of a positive month at 37.70%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
PCSA 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Aug 2026 | $0.18 | $0.19 | $0.19 | -90.77% |
| Sep 2026 | $0.20 | $0.24 | $0.26 | -88.27% |
| Oct 2026 | $0.15 | $0.20 | $0.23 | -90.52% |
| Nov 2026 | $0.16 | $0.20 | $0.23 | -90.14% |
| Dec 2026 | $0.18 | $0.21 | $0.24 | -89.73% |
2026 年，Processa Pharmaceuticals Inc（PCSA）預計區間為 $0.15 至 $0.26。
Processa Pharmaceuticals Inc 2026 年月度預測
2026 年 Aug，Processa Pharmaceuticals Inc 預計均價 $0.19，最低 $0.18，最高 $0.19。
2026 年 Sep，Processa Pharmaceuticals Inc 預計均價 $0.24，最低 $0.20，最高 $0.26。
2026 年 Oct，Processa Pharmaceuticals Inc 預計均價 $0.20，最低 $0.15，最高 $0.23。
2026 年 Nov，Processa Pharmaceuticals Inc 預計均價 $0.20，最低 $0.16，最高 $0.23。
2026 年 Dec，Processa Pharmaceuticals Inc 預計均價 $0.21，最低 $0.18，最高 $0.24。
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。